Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 310

1.

Trends in, and factors associated with, HIV infection amongst tuberculosis patients in the era of anti-retroviral therapy: a retrospective study in England, Wales and Northern Ireland.

Winter JR, Stagg HR, Smith CJ, Lalor MK, Davidson JA, Brown AE, Brown J, Zenner D, Lipman M, Pozniak A, Abubakar I, Delpech V.

BMC Med. 2018 Jun 7;16(1):85. doi: 10.1186/s12916-018-1070-2.

2.

Direct whole genome sequencing of sputum accurately identifies drug resistant Mycobacterium tuberculosis faster than MGIT culture sequencing.

Doyle RM, Burgess C, Williams R, Gorton R, Booth H, Brown J, Bryant JM, Chan J, Creer D, Holdstock J, Kunst H, Lozewicz S, Platt G, Yara Romero E, Speight G, Tiberi S, Abubakar I, Lipman M, McHugh TD, Breuer J.

J Clin Microbiol. 2018 May 30. pii: JCM.00666-18. doi: 10.1128/JCM.00666-18. [Epub ahead of print]

3.

A review on the ethnomedicinal uses, phytochemistry and pharmacology of Alpinia officinarum Hance.

Abubakar IB, Malami I, Yahaya Y, Sule SM.

J Ethnopharmacol. 2018 May 25;224:45-62. doi: 10.1016/j.jep.2018.05.027. [Epub ahead of print] Review.

PMID:
29803568
4.

Exploring the determinants of open defecation in Nigeria using demographic and health survey data.

Abubakar IR.

Sci Total Environ. 2018 May 16;637-638:1455-1465. doi: 10.1016/j.scitotenv.2018.05.104. [Epub ahead of print]

PMID:
29801238
5.

Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort.

Jackson C, Southern J, Lalvani A, Drobniewski F, Griffiths CJ, Lipman M, Bothamley GH, Deeks JJ, Imran A, Kon OM, Mpofu S, Nikolayevskyy V, Rees-Roberts M, Sitch A, Sridhar S, Tsou CY, Whitworth H, Abubakar I.

Thorax. 2018 May 15. pii: thoraxjnl-2017-211124. doi: 10.1136/thoraxjnl-2017-211124. [Epub ahead of print]

PMID:
29764958
6.

The use of whole-genome sequencing in cluster investigation of an MDR-TB outbreak.

Lalor MK, Casali N, Walker TM, Anderson LF, Davidson JA, Ratna N, Mullarkey C, Gent M, Foster K, Brown T, Magee J, Barrett A, Crook DW, Drobniewski F, Thomas HL, Abubakar I.

Eur Respir J. 2018 May 10. pii: 1702313. doi: 10.1183/13993003.02313-2017. [Epub ahead of print] No abstract available.

PMID:
29748309
7.

Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium.

Abubakar I, Matteelli A, de Vries G, Zenner D, Cirillo DM, Lönnroth K, Popescu G, Barcellini L, Story A, Migliori GB.

Eur Respir J. 2018 May 10;51(5). pii: 1702604. doi: 10.1183/13993003.02604-2017. Print 2018 May. No abstract available.

PMID:
29748241
8.

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update.

Migliori GB, Sotgiu G, Rosales-Klintz S, Centis R, D'Ambrosio L, Abubakar I, Bothamley G, Caminero JA, Cirillo DM, Dara M, de Vries G, Aliberti S, Dinh-Xuan AT, Duarte R, Midulla F, Solovic I, Subotic DR, Amicosante M, Correia AM, Cirule A, Gualano G, Kunst H, Palmieri F, Riekstina V, Tiberi S, Verduin R, van der Werf MJ.

Eur Respir J. 2018 May 17;51(5). pii: 1702678. doi: 10.1183/13993003.02678-2017. Print 2018 May.

PMID:
29678945
9.

Accuracy of an automated system for tuberculosis detection on chest radiographs in high-risk screening.

Melendez J, Hogeweg L, Sánchez CI, Philipsen RHHM, Aldridge RW, Hayward AC, Abubakar I, van Ginneken B, Story A.

Int J Tuberc Lung Dis. 2018 May 1;22(5):567-571. doi: 10.5588/ijtld.17.0492.

10.

Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era.

Gupta RK, Lipman M, Story A, Hayward A, de Vries G, van Hest R, Erkens C, Rangaka MX, Abubakar I.

Int J Tuberc Lung Dis. 2018 May 1;22(5):479-487. doi: 10.5588/ijtld.17.0767.

PMID:
29663951
11.

Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions.

Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA.

Lancet Infect Dis. 2018 Apr 10. pii: S1473-3099(18)30134-8. doi: 10.1016/S1473-3099(18)30134-8. [Epub ahead of print] Review.

PMID:
29653698
12.

Humanitarian disaster for Rohingya refugees: impending natural hazards and worsening public health crises.

Ahmed B, Orcutt M, Sammonds P, Burns R, Issa R, Abubakar I, Devakumar D.

Lancet Glob Health. 2018 May;6(5):e487-e488. doi: 10.1016/S2214-109X(18)30125-6. No abstract available.

13.

Synergistic Apoptotic Effects of Tocotrienol Isomers and Acalypha wilkesiana on A549 and U87MG Cancer Cells.

Abubakar IB, Lim SW, Loh HS.

Trop Life Sci Res. 2018 Mar;29(1):229-238. doi: 10.21315/tlsr2018.29.1.15. Epub 2018 Mar 2.

14.

Hepatitis C virus treatment as prevention in people who inject drugs.

White PJ, Abubakar I.

Lancet Infect Dis. 2018 Apr;18(4):379. doi: 10.1016/S1473-3099(18)30130-0. Epub 2018 Mar 21. No abstract available.

PMID:
29582763
15.

Update in Tuberculosis and Nontuberculous Mycobacteria 2017.

Abubakar I, Gupta RK, Rangaka MX, Lipman M.

Am J Respir Crit Care Med. 2018 May 15;197(10):1248-1253. doi: 10.1164/rccm.201801-0106UP. No abstract available.

PMID:
29537298
16.

UK's role in global health research innovation.

Mannell J, Abubakar I, Bastawrous A, Osrin D, Patel P, Piot P, Prince M, Smith J, Wilkinson RJ, Horton R.

Lancet. 2018 Feb 24;391(10122):721-723. doi: 10.1016/S0140-6736(18)30303-9. No abstract available.

PMID:
29486932
17.

Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey.

Adetifa IMO, Adamu AL, Karani A, Waithaka M, Odeyemi KA, Okoromah CAN, Bello MM, Abubakar IS, Inem V, Scott JAG.

Sci Rep. 2018 Feb 22;8(1):3509. doi: 10.1038/s41598-018-21837-5.

18.

Assessment of data quality and reporting systems for underserved populations: the case of integrated community case management programs in Nigeria.

Nyangara FM, Hai T, Zalisk K, Ozor L, Ufere J, Isiguzo C, Abubakar IN.

Health Policy Plan. 2018 May 1;33(4):465-473. doi: 10.1093/heapol/czy003.

PMID:
29447403
19.

Comparing different technologies for active TB case-finding among the homeless: a transmission-dynamic modelling study.

Mugwagwa T, Stagg HR, Abubakar I, White PJ.

Sci Rep. 2018 Jan 23;8(1):1433. doi: 10.1038/s41598-018-19757-5.

20.

The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital: a retrospective cohort analysis.

Adamu AL, Aliyu MH, Galadanci NA, Musa BM, Lawan UM, Bashir U, Abubakar I.

Int J Equity Health. 2018 Jan 8;17(1):4. doi: 10.1186/s12939-017-0714-8.

21.

Eliminating tuberculosis in low-burden countries.

Jackson C, Cohen T, Rangaka MX, Abubakar I.

Int J Tuberc Lung Dis. 2018 Jan 1;22(1):3. doi: 10.5588/ijtld.17.0707. No abstract available.

PMID:
29297418
22.

Assessing uncertainty in the burden of hepatitis C virus: Comparison of estimated disease burden and treatment costs in the UK.

Gubay F, Staunton R, Metzig C, Abubakar I, White PJ.

J Viral Hepat. 2018 May;25(5):514-523. doi: 10.1111/jvh.12847. Epub 2018 Mar 1.

23.

Using peer advocates to improve access to services among hard-to-reach populations with hepatitis C: a qualitative study of client and provider relationships.

MacLellan J, Surey J, Abubakar I, Stagg HR, Mannell J.

Harm Reduct J. 2017 Nov 28;14(1):76. doi: 10.1186/s12954-017-0202-x.

24.

Post-migration follow-up of migrants at risk of tuberculosis.

White PJ, Abubakar I, Aldridge RW, Hayward AC.

Lancet Infect Dis. 2017 Nov;17(11):1124. doi: 10.1016/S1473-3099(17)30567-4. No abstract available.

PMID:
29115264
25.

5,6-dehydrokawain from the rhizome of Alpinia mutica Roxb. induced proangiogenic tumour-derived VEGF of HT-29 colorectal cancer.

Malami I, Muhammad A, Abubakar IB, Etti IC, Waziri PM, Abubakar RM, Mshelia HE.

Nat Prod Res. 2017 Oct 20:1-4. doi: 10.1080/14786419.2017.1392954. [Epub ahead of print]

PMID:
29052437
26.

Aiming for zero tuberculosis transmission in low-burden countries.

Marais BJ, Walker TM, Cirillo DM, Raviglione M, Abubakar I, van der Werf MJ, Boehme C, Niemann S, Castro KG, Zumla A, Sintchenko V, Crook DW.

Lancet Respir Med. 2017 Nov;5(11):846-848. doi: 10.1016/S2213-2600(17)30382-X. Epub 2017 Oct 13. No abstract available.

PMID:
29033268
27.

Tackling viral haemorrhagic fever in Africa.

Ihekweazu C, Abubakar I.

Lancet. 2017 Dec 16;390(10113):2612-2614. doi: 10.1016/S0140-6736(17)32475-3. Epub 2017 Oct 12. No abstract available.

28.

The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.

Mangtani P, Nguipdop-Djomo P, Keogh RH, Sterne JAC, Abubakar I, Smith PG, Fine PEM, Vynnycky E, Watson JM, Elliman D, Lipman M, Rodrigues LC.

Int J Epidemiol. 2018 Feb 1;47(1):193-201. doi: 10.1093/ije/dyx141.

PMID:
29025083
29.

Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV.

Winter JR, Stagg HR, Smith CJ, Brown AE, Lalor MK, Lipman M, Pozniak A, Skingsley A, Kirwan P, Yin Z, Thomas HL, Delpech V, Abubakar I.

AIDS. 2017 Nov 13;31(17):2403-2413. doi: 10.1097/QAD.0000000000001635.

PMID:
28857827
30.

Infectious causes of microcephaly: epidemiology, pathogenesis, diagnosis, and management.

Devakumar D, Bamford A, Ferreira MU, Broad J, Rosch RE, Groce N, Breuer J, Cardoso MA, Copp AJ, Alexandre P, Rodrigues LC, Abubakar I.

Lancet Infect Dis. 2018 Jan;18(1):e1-e13. doi: 10.1016/S1473-3099(17)30398-5. Epub 2017 Aug 30. Review.

PMID:
28844634
31.

Deaths during tuberculosis treatment among paediatric patients in a large tertiary hospital in Nigeria.

Adamu AL, Aliyu MH, Galadanci NA, Musa BM, Gadanya MA, Gajida AU, Amole TG, Bello IW, Gambo S, Abubakar I.

PLoS One. 2017 Aug 17;12(8):e0183270. doi: 10.1371/journal.pone.0183270. eCollection 2017.

32.

End of the Road for Adjunctive Vitamin D Therapy for Pulmonary Tuberculosis?

Abubakar I, Kloprogge F.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):544-545. doi: 10.1164/rccm.201707-1509ED. No abstract available.

PMID:
28759259
33.

Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.

Mangtani P, Nguipdop-Djomo P, Keogh RH, Trinder L, Smith PG, Fine PE, Sterne J, Abubakar I, Vynnycky E, Watson J, Elliman D, Lipman M, Rodrigues LC.

Health Technol Assess. 2017 Jul;21(39):1-54. doi: 10.3310/hta21390.

34.

Tuberculosis treatment outcomes among disadvantaged patients in India.

Jackson C, Stagg HR, Doshi A, Pan D, Sinha A, Batra R, Batra S, Abubakar I, Lipman M.

Public Health Action. 2017 Jun 21;7(2):134-140. doi: 10.5588/pha.16.0107.

35.

Consequence of prioritising pathogens for global antibiotic research.

Abubakar I, Strain H.

Lancet Infect Dis. 2017 Jul;17(7):690-691. doi: 10.1016/S1473-3099(17)30334-1. Epub 2017 Jun 21. No abstract available.

PMID:
28653630
36.

Household Response to Inadequate Sewerage and Garbage Collection Services in Abuja, Nigeria.

Abubakar IR.

J Environ Public Health. 2017;2017:5314840. doi: 10.1155/2017/5314840. Epub 2017 May 29.

37.

Capacity strengthening through pre-migration tuberculosis screening programmes: IRHWG experiences.

Douglas P, Posey DL, Zenner D, Robson J, Abubakar I, Giovinazzo G.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):737-745. doi: 10.5588/ijtld.17.0019.

PMID:
28633697
38.

Recent household transmission of tuberculosis in England, 2010-2012: retrospective national cohort study combining epidemiological and molecular strain typing data.

Lalor MK, Anderson LF, Hamblion EL, Burkitt A, Davidson JA, Maguire H, Abubakar I, Thomas HL.

BMC Med. 2017 Jun 13;15(1):105. doi: 10.1186/s12916-017-0864-y.

39.

Standard operating procedures for tuberculosis care.

Solovic I, Abubakar I, Sotgiu G, Dara M, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Ward B, Teixeira V, Gratziou C, Migliori GB.

Eur Respir J. 2017 Jun 1;49(6). pii: 1700515. doi: 10.1183/13993003.00515-2017. Print 2017 Jun. No abstract available.

PMID:
28572129
40.

Enhancement of apoptotic activities on brain cancer cells via the combination of γ-tocotrienol and jerantinine A.

Abubakar IB, Lim KH, Kam TS, Loh HS.

Phytomedicine. 2017 Jul 1;30:74-84. doi: 10.1016/j.phymed.2017.03.004. Epub 2017 Mar 10.

PMID:
28545672
41.

Going to scale: design and implementation challenges of a program to increase access to skilled birth attendants in Nigeria.

Okeke EN, Pitchforth E, Exley J, Glick P, Abubakar IS, Chari AV, Bashir U, Gu K, Onwujekwe O.

BMC Health Serv Res. 2017 May 18;17(1):356. doi: 10.1186/s12913-017-2284-2.

42.

Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure.

Metzig C, Surey J, Francis M, Conneely J, Abubakar I, White PJ.

Sci Rep. 2017 May 12;7(1):1833. doi: 10.1038/s41598-017-01862-6.

43.

Immigrant Arrival and Tuberculosis among Large Immigrant- and Refugee-Receiving Countries, 2005-2009.

White Z, Painter J, Douglas P, Abubakar I, Njoo H, Archibald C, Halverson J, Robson J, Posey DL.

Tuberc Res Treat. 2017;2017:8567893. doi: 10.1155/2017/8567893. Epub 2017 Mar 23.

44.

Ending tuberculosis in risk groups in Europe: challenges from travel and population movement.

Jackson C, Abubakar I.

Euro Surveill. 2017 Mar 23;22(12). pii: 30489. doi: 10.2807/1560-7917.ES.2017.22.12.30489. No abstract available.

45.

Sustaining tuberculosis decline in the UK.

Adam BU, Cosford P, Anderson SR, Abubakar I.

Lancet. 2017 Mar 25;389(10075):1176-1177. doi: 10.1016/S0140-6736(17)30755-9. No abstract available.

PMID:
28353429
46.

Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials.

Zumla A, Abubakar I.

Lancet Respir Med. 2017 Apr;5(4):247-248. doi: 10.1016/S2213-2600(17)30091-7. No abstract available.

PMID:
28353422
47.

High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study.

Adamu AL, Gadanya MA, Abubakar IS, Jibo AM, Bello MM, Gajida AU, Babashani MM, Abubakar I.

BMC Infect Dis. 2017 Feb 23;17(1):170. doi: 10.1186/s12879-017-2249-4.

48.

Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.

Davidson JA, Loutet MG, O'Connor C, Kearns C, Smith RM, Lalor MK, Thomas HL, Abubakar I, Zenner D.

Emerg Infect Dis. 2017 Mar;23(3):377-386. doi: 10.3201/eid2303.161408.

49.

C-Tb: a latent tuberculosis skin test for the 21st century?

Abubakar I, Jackson C, Rangaka MX.

Lancet Respir Med. 2017 Apr;5(4):236-237. doi: 10.1016/S2213-2600(17)30012-7. Epub 2017 Feb 1. No abstract available.

PMID:
28159607
50.

Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.

O'Connor J, Vjecha MJ, Phillips AN, Angus B, Cooper D, Grinsztejn B, Lopardo G, Das S, Wood R, Wilkin A, Klinker H, Kantipong P, Klingman KL, Jilich D, Herieka E, Denning E, Abubakar I, Gordin F, Lundgren JD; INSIGHT START study group.

Lancet HIV. 2017 Mar;4(3):e105-e112. doi: 10.1016/S2352-3018(16)30216-8. Epub 2017 Jan 5.

Supplemental Content

Loading ...
Support Center